Scarica l'app Stockscreener
11.62
3.09%
-0.37
Dopo l'orario di chiusura:
11.55
-0.07
-0.60%
Precedente Chiudi:
$11.99
Aprire:
$12.48
Volume 24 ore:
72,957
Relative Volume:
3.13
Capitalizzazione di mercato:
$122.55M
Reddito:
$72.33M
Utile/perdita netta:
$-8.38M
Rapporto P/E:
-14.74
EPS:
-0.7881
Flusso di cassa netto:
$-4.95M
1 W Prestazione:
+7.79%
1M Prestazione:
+7.03%
6M Prestazione:
-50.49%
1 anno Prestazione:
+31.00%
Intervallo 1D:
$11.34
$12.50
Intervallo di 1 settimana:
$10.16
$13.26
Portata 52W:
$6.79
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Nome
Burning Rock Biotech Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare BNR vs TMO, DHR, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
11.62 | 126.45M | 72.33M | -8.38M | -4.95M | -0.7881 |
TMO
Thermo Fisher Scientific Inc
|
603.18 | 223.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
200.53 | 144.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
326.14 | 47.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
257.30 | 42.30B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
143.12 | 40.81B | 7.23B | 1.41B | 1.09B | 4.979 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2020-07-07 | Iniziato | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Borsa (BNR) Ultime notizie
Aesthetic Medical International Holdings Group Ltd (AIH) Peer Comparison – Compare with Others - Value Research
Concord Medical Services Holdings LimitedADR Peer Comparison – Compare with Others - Value Research
Burning Rock Biotech Ltd StockBNR Share Price Today, News and Discussion - Stocktwits
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 3.7%What's Next? - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – FWB:6BU0 - TradingView
Burning Rock Biotech Limited Sponsored ADR $BNR Shares Sold by Crcm LP - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to EBITDA forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Burning Rock CEO purchases $618,218 in company shares - Investing.com
Burning Rock Announces Founder’s Purchase of Its ADSs - Barchart.com
Burning Rock Biotech Ltd. Sponsored ADR Financial Disclosures & Filings - TradingView
Enterprise value to EBIT forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to book forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to earnings forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:BNR) - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (LS:A40AE6) - TradingView
Why These High-Flying Stocks Came Back To Earth - Sahm
BNRBurning Rock Biotech Ltd ADR Stock Price and Quote - Finviz
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01Momentum ETF - newsline.com
ETFs Investing in Burning Rock Biotech Ltd. Sponsored ADR Stocks - TradingView
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Earnings BeforeStock ScreenerSnapshot - Finviz
Burning Rock Biotech (NASDAQ: BNR) 2025 loss narrows amid China and HFCAA risks - Stock Titan
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 1.3%What's Next? - MarketBeat
Cancer screening company Faces Tough IPO Test As Market Cools - Benzinga
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer By Investing.com - Investing.com South Africa
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer - Investing.com
Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock - MarketBeat
Burning Rock CEO purchases $546,604 in company shares - Investing.com
Burning Rock CEO purchases $546,604 in company shares By Investing.com - Investing.com India
Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 9.8%Here's What Happened - MarketBeat
(BNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Burning Rock Biotech (BNR) Stock Price, News & Analysis $BNR - MarketBeat
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results - Barchart.com
Intel and AMD among market cap stock movers on Friday By Investing.com - Investing.com Australia
Alibaba and Facebook among market cap stock movers on Thursday - Investing.com
Burning Rock Announces Results of 2025 Annual General Meeting - Barchart.com
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Yahoo Finance
Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - Barchart.com
KindlyMD (NAKA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
BNR: Revenue up 9.6% and net loss narrowed, with strong pharma R&D and cost controls - TradingView
BNR: Net loss narrowed 89% year-over-year as pharma R&D revenue surged and margins improved - TradingView
BNR: 2024 revenue fell 4% to RMB515.8M, net loss narrowed 47%, in-hospital segment now leads - TradingView
BNR: Commercial breakeven reached in FY2024, with strong margins and leadership in early cancer detection - TradingView
US Stock Market Trends: Updated Data Analysis & Real-Time Quotes - TradingKey
BNR: Net loss narrowed and gross margin improved as in-hospital and pharma R&D revenues grew - TradingView
BNR: In-hospital revenue rose 11.2% and net loss narrowed as the business shifted away from central-lab testing - TradingView
Japan Multi Cancer Early Detection Market Outlook, 2030 - Grand View Research
Burning Rock Biotech Ltd Adr Azioni (BNR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):